Bamlanivimab plus etesevimab therapy induces SARS-CoV-2 immune escape mutations and secondary clinical deterioration in COVID-19 patients with B-cell malignancies

Affiliation auteurs!!!! Error affiliation !!!!
TitreBamlanivimab plus etesevimab therapy induces SARS-CoV-2 immune escape mutations and secondary clinical deterioration in COVID-19 patients with B-cell malignancies
Type de publicationJournal Article
Year of Publication2021
AuteursPommeret F., Colomba J., Bigenwald C., Laparra A., Bockel S., Bayle A., Michot J.-M, Hueso T., Albiges L., Tiberghien P., Marot S., Jary A., Lacombe K., Barlesi F., Griscelli F., Colomba E.
JournalANNALS OF ONCOLOGY
Volume32
Pagination1445-1447
Date PublishedNOV
Type of ArticleLetter
ISSN0923-7534
DOI10.1016/j.annonc.2021.07.015